Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| CMMB (Chemomab Therapeutics Ltd.) | 7.27% | -66.48% | -36.15% | -52.83% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 02/13/2019
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| CMMB (Chemomab Therapeutics Ltd.) | 02/13/2019 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -11.50 | -66.48 | -36.15 | -52.83 | NA | NA | NA | … | … | 7.27 | -77.21 | 254.90 | -84.06 | -53.62 | -75.07 | 23.57 | -84.70 |
| Sharpe Ratio | NA | -0.95 | -0.41 | -0.64 | NA | NA | NA | … | … | 0.70 | -1.14 | 2.58 | -0.98 | -0.70 | -0.42 | 0.17 | -1.12 |
| Standard Deviation(%) | NA | 69.63 | 87.37 | 83.73 | NA | NA | NA | … | … | 82.62 | 70.39 | 97.26 | 89.54 | 78.66 | 180.50 | 133.75 | 80.16 |
| Draw Down(%) | NA | 73.53 | 85.37 | 98.49 | NA | NA | NA | … | … | 31.78 | 83.20 | 54.07 | 85.94 | 73.61 | 94.97 | 62.03 | 86.29 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 02/13/2019
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CMMB (Chemomab Therapeutics Ltd.) |
-77.18%
Feb 2021 – Feb 2024 |
-62.75%
Mar 2019 – Mar 2024 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CMMB (Chemomab Therapeutics Ltd.) |
-24.61%
Apr 2022 – Apr 2025 |
-34.91%
Feb 2020 – Feb 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart